NASDAQ: UTHR       United Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
107.66   -2.38 (2.16%)  107.73 - 112.71  216,585


Avg Volume (4 weeks):555,015
4 Weeks Range:107.73 - 139.54
4 Weeks Price Volatility (%):
52 Weeks Range:107.73 - 152.55
52 Weeks Price Volatility (%):
Average Price Target: 147.00
Price Target Upside/Downside: +39.34


No recent Headlines for this stock.

Business Background

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution (Tyvaso); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). The Company markets and sells an oncology product in the United States, Unituxin (dinutuximab) Injection (Unituxin), which is approved for treatment of neuroblastoma. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies.

  Be the first to like this.


2964  4504  476  612 

Top 10 Active Counters
 FB 162.80-9.76 
 GE 13.675-0.395 
 NVCN 0.111-0.013 
 TWTR 30.67-4.31 
 ORCL 47.075-4.875 
 AMD 11.14-0.29 
 ENRJ 0.393+0.102 
 EEM 49.16+0.48 
 MU 60.95+0.81 
 SPY 270.43-0.06 
Partners & Brokers